secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001396814-23-000045
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira board rejects Gary Pace's resignation after withhold vote; plans diverse director additions
--------------------------------------------------------------------------------

- At June 13 annual meeting, Dr. Gary Pace received more withhold than for votes in Class III director election.
- Pace tendered resignation per majority-vote policy; independent directors unanimously rejected it.
- Board engaged independent search firm to identify diverse candidates; expects to refresh board composition soon.
- Pace will continue as Class III director until 2026 annual meeting or until successor elected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000045/0001396814-23-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000045/pcrx-20230907.htm
  HTML page:      https://secwatch.observer/filing/0001396814-23-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer